Format

Send to

Choose Destination
Cancer Cell. 2009 Jun 2;15(6):489-500. doi: 10.1016/j.ccr.2009.03.022.

A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

Author information

1
Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA 94306, USA.

Abstract

K-ras mutations occur frequently in epithelial cancers. Using short hairpin RNAs to deplete K-Ras in lung and pancreatic cancer cell lines harboring K-ras mutations, two classes were identified-lines that do or do not require K-Ras to maintain viability. Comparing these two classes of cancer cells revealed a gene expression signature in K-Ras-dependent cells, associated with a well-differentiated epithelial phenotype, which was also seen in primary tumors. Several of these genes encode pharmacologically tractable proteins, such as Syk and Ron kinases and integrin beta6, depletion of which induces epithelial-mesenchymal transformation (EMT) and apoptosis specifically in K-Ras-dependent cells. These findings indicate that epithelial differentiation and tumor cell viability are associated, and that EMT regulators in "K-Ras-addicted" cancers represent candidate therapeutic targets.

PMID:
19477428
PMCID:
PMC2743093
DOI:
10.1016/j.ccr.2009.03.022
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center